巨细胞动脉炎超声Halo评分与内膜增生及缺血性视力丧失相关
这项前瞻性研究纳入90例疑似巨细胞动脉炎(GCA)患者,基线时均行颞动脉及腋动脉超声并完成颞动脉活检(TAB)。活检阳性者Halo评分高于阴性者;与Halo评分升高相关的是活检中的内膜增生,而非透壁炎症或巨细胞。Halo评分区分伴与不伴内膜增生的TAB阳性患者曲线下面积为0.82,且伴内膜增生的TAB阳性患者更常出现眼部缺血。
要点
- Halo评分升高与颞动脉活检中的内膜增生相关,而非透壁炎症或巨细胞。
- Halo评分区分TAB阳性患者伴与不伴内膜增生的AUC为0.82。
- 伴内膜增生的TAB阳性GCA患者眼部缺血发生率为40%,高于其他GCA患者的13-14%。
核心结论
- 超声Halo评分可能有助于识别存在内膜增生的GCA患者亚群,该活检特征与缺血性视力丧失相关。
研究设计与样本
- 前瞻性研究,纳入90例疑似GCA患者,基线时均行颞动脉与腋动脉超声及颞动脉活检。
- 由经验丰富的病理学家评估活检是否符合GCA,以及是否存在透壁炎症、巨细胞和内膜增生。
- 测定超声Halo评分并进行受试者工作特征(ROC)分析。
主要发现
- TAB阳性患者Halo评分高于TAB阴性患者。
- 在GCA患者中,活检内膜增生的存在而非透壁炎症或巨细胞的存在与Halo评分升高相关。
- Halo评分区分TAB阳性患者伴与不伴内膜增生的AUC为0.82。
- TAB阳性且伴内膜增生者眼部缺血发生率为40%,其他GCA患者为13-14%。
关键数值与推荐
- ROC分析显示Halo评分区分TAB阳性患者伴与不伴内膜增生的曲线下面积(AUC)为0.82。
- TAB阳性且内膜增生者眼部缺血发生率40%,其他GCA患者为13-14%。
临床怎么用
- 对疑似GCA患者行颞动脉及腋动脉超声测定Halo评分,可辅助识别内膜增生相关的高缺血风险亚群。
- Halo评分升高提示需关注眼部缺血风险,但本研究的评分阈值原文未报告,不能据此设定cut-off。
局限性
- 原文摘要未报告样本量以外的设计细节(如盲法、评分者可重复性)及Halo评分具体阈值。
- 随访6个月用于TAB阴性者的临床诊断,随访时长有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: We investigated the relationship between the ultrasonographic Halo Score and temporal artery biopsy (TAB) findings in GCA. METHODS: This is a prospective study including 90 patients suspected of having GCA. Ultrasonography of temporal/axillary arteries and a TAB were obtained in all patients at baseline. An experienced pathologist evaluated whether TAB findings were consistent with GCA, and whether transmural inflammation, giant cells and intimal hyperplasia were present. Ultrasonographic Halo Scores were determined. Receiver operating characteristic analysis was performed. RESULTS: Twenty-seven patients had a positive TAB, while 32 patients with a negative TAB received a clinical diagnosis of GCA after 6 months of follow-up. Patients with a positive TAB showed higher Halo Scores than patients with a negative TAB. The presence of intimal hyperplasia in the biopsy, rather than the presence of transmural inflammation or giant cells, was associated with elevated Halo Scores in patients with GCA. The Halo Score discriminated well between TAB-positive patients with and without intimal hyperplasia, as indicated by an area under the curve of 0.82 in the receiver operating characteristic analysis. Patients with a positive TAB and intimal hyperplasia more frequently presented with ocular ischaemia (40%) than the other patients with GCA (13-14%). CONCLUSION: The ultrasonographic Halo Score may help to identify a subset of GCA patients with intimal hyperplasia, a TAB feature associated with ischaemic sight loss.
引用
- van der Geest KSM, Wolfe K, Borg F, et al. Ultrasonographic Halo Score in giant cell arteritis: association with intimal hyperplasia and ischaemic sight loss. Rheumatology (Oxford). 2021. PMID: 33355340. doi:10.1093/rheumatology/keaa806
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。